These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38671349)

  • 1. Predicting chronic kidney disease progression with artificial intelligence.
    Isaza-Ruget MA; Yomayusa N; González CA; H CA; de Oro V FA; Cely A; Murcia J; Gonzalez-Velez A; Robayo A; Colmenares-Mejía CC; Castillo A; Conde MI
    BMC Nephrol; 2024 Apr; 25(1):148. PubMed ID: 38671349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
    Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
    BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitions of progression in chronic kidney disease--predictors and relationship to renal replacement therapy in a population cohort with a 6 year follow-up.
    Marks A; Fluck N; Prescott GJ; Robertson LM; Simpson WG; Smith WC; Black C
    Nephrol Dial Transplant; 2014 Feb; 29(2):333-41. PubMed ID: 24081862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?
    Lee MJ; Park JH; Moon YR; Jo SY; Yoon D; Park RW; Jeong JC; Park I; Shin GT; Kim H
    PLoS One; 2018; 13(10):e0204586. PubMed ID: 30286208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a machine learning model to predict time to renal replacement therapy in patients with chronic kidney disease.
    Okita J; Nakata T; Uchida H; Kudo A; Fukuda A; Ueno T; Tanigawa M; Sato N; Shibata H
    BMC Nephrol; 2024 Mar; 25(1):101. PubMed ID: 38493099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation.
    Schroeder EB; Yang X; Thorp ML; Arnold BM; Tabano DC; Petrik AF; Smith DH; Platt RW; Johnson ES
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):87-94. PubMed ID: 28028051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning algorithms for predicting renal replacement therapy initiation in CKD patients: a retrospective cohort study.
    Leung KC; Ng WW; Siu YP; Hau AK; Lee HK
    BMC Nephrol; 2024 Mar; 25(1):95. PubMed ID: 38486160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
    Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
    Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of patient-reported renal replacement therapy planning discussions by disease severity among children and young adults with chronic kidney disease.
    Ng DK; Xu Y; Hogan J; Saland JM; Greenbaum LA; Furth SL; Warady BA; Wong CS
    Pediatr Nephrol; 2020 Oct; 35(10):1925-1933. PubMed ID: 32363486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
    Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
    BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking to the future: predicting renal replacement outcomes in a large community cohort with chronic kidney disease.
    Marks A; Fluck N; Prescott GJ; Robertson L; Simpson WG; Cairns Smith W; Black C
    Nephrol Dial Transplant; 2015 Sep; 30(9):1507-17. PubMed ID: 25943597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
    Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with kidney disease progression and mortality in a referred CKD population.
    Hoefield RA; Kalra PA; Baker P; Lane B; New JP; O'Donoghue DJ; Foley RN; Middleton RJ
    Am J Kidney Dis; 2010 Dec; 56(6):1072-81. PubMed ID: 20692750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
    Ekart R; Ferjuc A; Furman B; Gerjevič Š; Bevc S; Hojs R
    Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.
    Mahmood U; Healy HG; Kark A; Cameron A; Wang Z; Abeysekera R; Hoy WE
    BMC Nephrol; 2017 Dec; 18(1):372. PubMed ID: 29282014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Creatinine and Chronic Kidney Disease-Epidemiology Estimated Glomerular Filtration Rate: Independent Predictors of Renal Replacement Therapy following Cardiac Surgery.
    Drosos G; Ampatzidou F; Sarafidis P; Karaiskos T; Madesis A; Boutou AK
    Am J Nephrol; 2018; 48(2):108-117. PubMed ID: 30110680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
    Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression and outcomes of non-dialysis dependent chronic kidney disease patients: A single center longitudinal follow-up study.
    Khan YH; Sarriff A; Adnan AS; Khan AH; Mallhi TH; Jummaat F
    Nephrology (Carlton); 2017 Jan; 22(1):25-34. PubMed ID: 26718476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.
    Misra S; Khosla A; Allred J; Harmsen WS; Textor SC; McKusick MA
    J Vasc Interv Radiol; 2016 Aug; 27(8):1215-24. PubMed ID: 27296703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.